Supplementary Figure S1. Comparison between idiopathic pulmonary fibrosis (IPF) bronchoalveolar lavage (BAL) samples (n = 193) and negative control samples (n = 12). Figure S2 . Bronchoalveolar lavage differential cell counts.
Supplementary
. Association between total number of leukocytes in bronchoalveolar lavage (BAL) fluid and bacterial burden. Figure S4 . Association between lung function and bronchoalveolar lavage (BAL) bacterial burden. Figure S5 . Bronchoalveolar lavage (BAL) bacterial burden of idiopathic pulmonary fibrosis (IPF) patients with either indeterminate or probable/definite usual interstitial pneumonia (UIP). Supplementary Table S1 . Information regarding specific treatments. Supplementary Table S2 . Bronchoalveolar lavage (BAL) differential cell counts and their prediction of BAL bacterial burden. Supplementary Table S3 . Agreement between two radiologist scorers measured by Cohen's kappa with squared ratings (k) or the interclass correlation coefficient (icc). Supplementary Table S1 . Information regarding specific treatments.

Treatment
IPF (N = 193)
*PPI n (%) 97 (91) **Oral corticosteroids n (%) 21 (11) Inhaled corticosteroids n (%) 36 (19) Subsequent antifibrotic therapy n (%) 67 (35) IPF: idiopathic pulmonary fibrosis; PPI: proton pump inhibitor; *PPI: 107/193 patients had concomitant gastroesophageal reflux. 97/107 patients were treated with PPI; **Steroids: 21/193 patients were administered prednisolone (<10mg/day). Supplementary Table S2 . Bronchoalveolar lavage (BAL) differential cell counts and their prediction of BAL bacterial burden. No association was seen between BAL cell differential (percentage of total cells) and bacterial burden (n = 193). 
Supplementary Table S3. Agreement between two radiologist scorers measured by
Cohen's kappa with squared ratings (k) or the interclass correlation coefficient (icc).
Variable Agreement
Fibrosis extent ( 
